Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 | NEJM

https://www.nejm.org/doi/full/10.1056/NEJMc2007575

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

To rapidly communicate information on the global clinical effort against Covid-19, the Journal has initiated a series of case reports that offer important teaching points or novel findings. The case reports should be viewed as observations rather than as recommendations for evaluation or treatment. In the interest of timeliness, these reports are evaluated by in-house editors, with peer review reserved for key points as needed.